(2R,3R)-1-BENZHYDRYL-2-METHYLAZETIDIN-3-OL, 95%, 100mg

1,10-phenanthroline monohydrate, min. 99%, pa, ACS, 50 g, glass packaging

(9H-FLUOREN-9-YL)METHYL (3-ETHYNYLPHENYL)CARBAMATE, 95.0%, 250mg

N-Phenylaza-15-crown 5-Ether>96.0%(GC)(T)1g

3-Amino-1-cyclobutylpyridin-2(1H)-one, 100mg

4-Chloro-benzo[b]thiophene-2-carboxylic acid methyl ester, 95.0%, 5g

Methyl 4-bromo-3-fluorothiophene-2-carboxylate, 95.0%, 5g

N-(4-Hydroxyphenyl)-2-chloropropanamide, 95%, 10g

1-(difluoromethyl)-1H-pyrazole-4-carboxylic acid, 500mg

2-Bromo-1,3-diethyl-5-methylbenzene, 95.0%, 5g

3-Bromo-6-iodo-2-methylanisole, 1g

7-Iodoquinazolin-4(1H)-one, 95.0%, 5g

Sodium Bis(trifluoromethanesulfonyl)imide>98.0%(T)5g